3 | SEC Filings Hub

Filing metadata

Accession number: 0001209191-23-052872
Form type: Form 3
Filer: Fusion Pharmaceuticals Inc.
CIK: CIK 1805890
Filed: Oct 16, 2023
Reporting period: Oct 16, 2023
Description: Initial ownership

Documents

0001209191-23-052872-index.htm

Complete submission

0001209191-23-052872.txt

directory listing

Filed by

Fusion Pharmaceuticals Inc.